Clinical Trials
24 trialsNCT04981119 2026-06-02
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
NCT06885424 2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
NCT05184790 2026-05-19
LEARN
University of Sydney
Recruiting
NCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT07327489 2026-01-08
ELEPHAS-05
Elephas
Recruiting
NCT05970471 2025-12-12
IMPLICATION
Centre Hospitalier Universitaire de Besancon
Completed
NCT03702309 2025-11-26
LIBERATE
University Health Network, Toronto
Recruiting
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT02821793 2025-07-01
PRIORITY
Institut Bergonié
Completed
NCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT03301493 2025-04-10
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
Completed
NCT04889495 2025-03-19
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Pfizer
Withdrawn
NCT05403177 2025-02-03
MOHCCN-O
University Health Network, Toronto
Recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT05878964 2024-10-04
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT03662204 2022-09-01
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Exact Sciences Corporation
Completed
NCT05154474 2022-05-03
SPACE2
Weprom
Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT02900248 2019-04-02
N1
CureOne
Terminated
NCT01236053 2017-07-06
Cancer in Patients With Gabapentin (GPRD)
GlaxoSmithKline
Completed
NCT01444456 2017-03-20
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Completed
NCT00896467 2013-07-10
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
National Cancer Institute (NCI)
Terminated